Lonza Group Ltd

LONN: XSWX (CHE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
CHF 287.00TwlpjzPkyhvqxx

Narrow-Moat Lonza Reports Solid 1H 2022; Maintaining CHF 620 FVE, Shares Moderately Undervalued

Lonza reported solid half-year results driven by continued strong demand in its biologics and cell and gene segments. Revenue totaled nearly CHF 3 billion, representing a 17% increase from the prior year. Lonza’s results were in line with our expectations, and we maintain our fair value estimate of CHF 620 per share. The stock is currently trading in 3-star territory, about 6% below our fair value estimate. We maintain our narrow economic moat rating and stable moat trend.

Sponsor Center